However, some recent studies have indicated that GLP-1 RA could increase the risk of pancreatic cancer [112], but the evidence is not conclusive, and more recent large-scale studies and meta-analyses have provided mixed results. The gene discussed is GCG; the disease is familial pancreatic carcinoma.